TOXR 21Shares XRP ETF

CBOE Commodity Contracts Brokers & Dealers DE CIK: 0002028835
AI RATING
SELL
45% Confidence

Investment Thesis

This ETF structure exhibits severe financial deterioration with $36M net losses on $247.7M assets (14.5% loss), indicating poor 2025 performance or significant fee drag relative to underlying XRP exposure. Critical data gaps prevent comprehensive analysis, with missing revenue, cash flow, and operational metrics typical of exchange-listed funds. While the fund maintains adequate solvency with minimal debt and substantial equity cushion, the absence of profitability and limited publicly available fundamentals create elevated uncertainty around fund viability and performance quality.

Strengths

  • + Zero leverage with negligible liabilities ($35.3K) reduces default risk
  • + Substantial equity base ($247.7M) provides buffer against further asset deterioration
  • + Conservative balance sheet structure with no debt burden

Risks

  • ! Significant net loss of $36M (14.5% of assets) signals poor fund performance or excessive fee structure
  • ! Severe data insufficiency with only 10 of ~30+ metrics available; missing revenue, cash flow, and profitability analysis
  • ! ETF structure with incomplete disclosures prevents assessment of expense ratios, AUM composition, and benchmark tracking efficiency
  • ! Negative ROE/ROA (-14.5%) indicates value destruction relative to shareholder equity

Key Metrics to Watch

Financial Metrics

Revenue
N/A
Net Income
-36.0M
EPS (Diluted)
$0.00
Free Cash Flow
N/A
Total Assets
247.7M
Cash
N/A

Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE -14.5%
ROA -14.5%
FCF Margin N/A

Balance Sheet & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
0.00x
Debt/Assets
0.0%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-17T17:06:24.335586 | Data as of: 2025-12-31 | Powered by Claude AI